Exabis Library
Welcome to the e-CCO Library!
P506: Serum infliximab and antibodies to infliximab levels in Crohn’s disease and ulcerative colitis patients on long-term maintenance therapy
2016
ECCO '16 Amsterdam
Friday, 22 February 2019, 9:49 AM
P506: Steroid treatment for longer than 2 weeks leading to admission predicts higher colectomy rates in children with acute severe ulcerative colitis
2019
ECCO '19 Copenhagen
Friday, 22 February 2019, 9:41 AM
P506: The Impact of Anxiety in Patients With Inflammatory Bowel Diseases Treated With Biologics during COVID Lockdown. A Comparative Study between Hospitalized and non-hospitalized patients
2021
ECCO'21 Virtual
Wednesday, 2 June 2021, 4:12 PM
P507 Ustekinumab: Medium-term outcomes from a UK multicentre real-world cohort
2020
ECCO'20 Vienna
Thursday, 30 January 2020, 10:12 AM
P507: Clinical role, optimal timing and frequency of measurement of serum infliximab levels and anti-infliximab antibody titres in patients with inflammatory bowel disease
2016
ECCO '16 Amsterdam
Friday, 22 February 2019, 9:49 AM
P507: Efficacy of Infliximab after failure of subcutaneous anti-TNF agents in patients with moderate-to-severe ulcerative colitis
2019
ECCO '19 Copenhagen
Friday, 22 February 2019, 9:41 AM
P507: Need for surgery in patients with ulcerative colitis in the era of biologic therapy.
2022
ECCO'22
Friday, 11 February 2022, 3:56 PM
P507: Nutrition status in pre-surgical Crohn's disease, active Crohn's disease, Crohn's disease in remission and ulcerative colitis in remission: a cross-sectional study
2017
ECCO '17 Barcelona
Wednesday, 20 February 2019, 10:36 AM
P507: United States and European patient perspectives on the impact of moderate-to-severe Ulcerative Colitis on sexual activity: Communicating Needs and Features of IBD Experiences (CONFIDE) survey
2023
ECCO’23 Copenhagen
Friday, 14 July 2023, 11:05 AM
P507: Vulvar Crohn’s disease: A challenging diagnosis
2021
ECCO'21 Virtual
Wednesday, 2 June 2021, 4:12 PM
P507: What is the impact of infliximab metaoptimisation on surgical rates and need-to-change-therapy in real-world practice for severe inflammatory bowel disease?
2018
ECCO '18 Vienna
Thursday, 21 February 2019, 9:14 AM
P508 Safety and efficacy of combining biological therapies together or with small molecules in patients with inflammatory bowel disease: A retrospective multicentre national observational case series study
2020
ECCO'20 Vienna
Thursday, 30 January 2020, 10:12 AM
P508: Association between clinical outcome and post induction CT-P13 trough levels at week 14, in patients with inflammatory bowel disease. Preliminary results in an observational multicentric study
2017
ECCO '17 Barcelona
Wednesday, 20 February 2019, 10:36 AM
P508: Does corticosteroid therapy affect prognosis in inflammatory bowel disease patients hospitalised with Clostridium difficile infection?
2019
ECCO '19 Copenhagen
Friday, 22 February 2019, 9:41 AM
P508: Dose adjustment in patients with moderate to severe ulcerative colitis: results from year 3 of the UNIFI maintenance study long-term extension
2021
ECCO'21 Virtual
Wednesday, 2 June 2021, 4:12 PM
P508: Pregnancy outcomes in patients with inflammatory bowel disease experiencing flare ups during foetal development
2016
ECCO '16 Amsterdam
Friday, 22 February 2019, 9:49 AM
P508: Response of hepatitis B vaccination in patients with inflammatory bowel disease; prospective observational study in Korea
2018
ECCO '18 Vienna
Thursday, 21 February 2019, 9:14 AM
P508: Sarcopenia is associated with increased rates of infectious post-operative complications in Crohn's disease patients
2023
ECCO’23 Copenhagen
Friday, 14 July 2023, 11:05 AM
P508: The impact of disease duration and early biologic treatment on transmural healing in Crohn’s disease
2022
ECCO'22
Friday, 11 February 2022, 3:56 PM
P509 Vedolizumab levels in breast milk: Results from a prospective, postmarketing, milk-only lactation study in nursing mothers with inflammatory bowel disease
2020
ECCO'20 Vienna
Thursday, 30 January 2020, 10:12 AM